Glipizide Tablet
Product Images NDC 55154-7987

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 55154-7987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipizide-structure.jpg (Glipizide Structure)

Glipizide-structure.jpg (Glipizide Structure)
Chemical structure of the active ingredient Glipizide. The illustration depicts the molecular composition including ring structures and functional groups characteristic of Glipizide.*
FDA Label Image

5mg Bag Label (42b5c836 1917 4be3 986d 9ebe3f1a9191 00)

5mg Bag Label (42b5c836 1917 4be3 986d 9ebe3f1a9191 00)
Text panel for Glipizide tablets, USP 5 mg, containing 10 tablets. The panel includes dosage information, storage instructions at controlled room temperature, RX only status, and a warning about the package not being child resistant and intended for institutional use only. It lists packaging and distribution details by Major Pharmaceuticals and Cardinal Health.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.